Fletcher, C.E.; Deng, L.; Orafidiya, F.; Yuan, W.; Lorentzen, M.P.G.S.; Cyran, O.W.; Varela-Carver, A.; Constantin, T.A.; Leach, D.A.; Dobbs, F.M.; Figueiredo, I.; Gurel, B.; Parkes, E.; Bogdan, D.; Pereira, R.R.; Zhao, S.G.; Neeb, A.; Issa, F.; Hester, J.; Kudo, H.; Liu, Y.; Philippou, Y.; Bristow, R.; Knudsen, K.; Bryant, R.J.; Feng, F.Y.; Reed, S.H.; Mills, Ian; de Bono, Bono; Bevan, C.L. (Journal article; Peer reviewed, 2022-03-22)
Background: miR-346 was identified as an activator of Androgen Receptor (AR) signalling that associates with DNA damage response (DDR)-linked transcripts in prostate cancer (PC). We sought to delineate the impact of miR-346 ...